News Regarding Low Testosterone
Exciting results from a clinical trial of experimental testosterone hormone therapy on men with advanced treatment-resistant prostate cancer. Read more about the study conducted at Johns Hopkins University School of Medicine in Baltimore here.
According to a new study, testosterone replacement therapy (TRT) appears to be safe in hypogonadal prostate cancer patients who have had definitive treatment and in those on active surveillance. Read more at Urology Times.
Men with obesity who have low free testosterone or high estradiol levels are at elevated risk for insulin resistance or developing type 2 diabetes vs. normal-weight men or men with obesity and higher free testosterone levels. Click here for more information.
Long-term testosterone therapy (TT) in hypogonadal men improves urinary function and erectile function compared with untreated controls. To read more about the study’s findings, visit Urology Times.
In a retrospective study of medical records, researchers from Stanford University and the University of Pennsylvania concluded that lowering testosterone levels in men with prostate cancer could be associated with an increased risk of developing dementia. To read more about the findings, click here.
PINEVILLE, N.C., Aug. 17, 2016 /PRNewswire/ — Low T Center, the leader in physician-led diagnosis and treatment of low testosterone, is expanding into North Carolina. The first North Carolina Low T Center is located on the outskirts of Charlotte, in nearby Pineville, NC with a second Charlotte location opening soon in Mooresville with Regional Medical Director, Dr. […]
Testosterone Replacement Therapy Has Major Protective Effects Several studies will be presented at the 111th Annual Scientific Meeting of the American Urological Association (AUA) that outline the possible protective effects of Testosterone Replacement Therapy. Five different studies will present evidence that treating Low T could help protect patients from increased risk of prostate cancer, cardiovascular […]
Study Shows That Patients Are Not Increasing Risk From Low T Treatment Research led by investigators at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center analyzed more than 250,000 medical records of men in Sweden and found that there is no correlation between testosterone replacement therapy and a higher risk of […]
SOUTHLAKE, TX (MAY 6, 2016) – Low T Center Founder and CEO, Mike Sisk and Richard Rawlings, mastermind of the Gas Monkey brand, have joined for the 100th Running of the Indy 500. Both companies, based in the heart of Texas in Dallas-Fort Worth, have found synergy with reaching sports minded men who have a […]
6-AUG-2015, by Jody A. Charnow, Endocrinology Advisor “…Low testosterone levels predict an increased likelihood of high-grade prostate cancer being found as a result of a prostate biopsy, new findings suggest…” To read the full article, visit http://goo.gl/u0H9bP